Table 3.
Outcome of medium-term and short-term lung cancer survivor.
| Characteristic | Lung cancer (n = 13) | Medium-term survivor (n = 5) | Short-term survivor (n = 8) | P value |
|---|---|---|---|---|
| Hospital stay (days) | 13.0 (11.0–18.0) | 13.0 (12.0–19.0) | 13.5 (10.5–16.5) | 1.000 |
| Most critical type during hospitalization | 0.841 | |||
| Mild/Moderate | 3 (23.1%) | 1 (20.0%) | 2 (25.0%) | |
| Severe/Critical | 10 (76.9%) | 4 (80.0%) | 6 (75.0%) | |
| Time from symptoms to hospitalization (days) | 10.0 (10.0–16.0) | 14.0 (10.0–16.0) | 10.0 (9.3–15.8) | 0.552 |
| Clinical symptoms remission time (days) | 12.0 (11.0–18.0) | 12.0 (11.0–19.0) | 13.0 (10.5–17.3) | 1.000 |
| Admission to intensive care unit | 0.221 | |||
| Yes | 2 (15.4%) | 0 (0%) | 2 (25.0%) | |
| No | 11 (84.6%) | 5 (100%) | 6 (75.0%) | |
| ICU stay (days) | 13.5 (11.3–15.8) | – | 13.5 (11.3–15.8) | – |
| Clinical outcomes | 0.429 | |||
| Discharge from hospital | 12 (92.3%) | 5 (100%) | 7 (87.5%) | |
| Death | 1 (7.7%) | 0 (0%) | 1 (12.5%) | |
| Time from diagnosis to death (days) | 18.0 (18.0–18.0) | – | 18.0 (18.0–18.0) | – |